CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
+32.81%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$123M
AUM Growth
+$123M
(+29%)
Cap. Flow
-$596K
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
69.68%
Holding
31
New
6
Increased
7
Reduced
12
Closed
4
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$5.02M |
| 2 |
Evolent Health
EVH
|
$3.58M |
| 3 |
Exact Sciences
EXAS
|
$2.88M |
| 4 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$2.63M |
| 5 |
GHDX
Genomic Health, Inc.
GHDX
|
$2.6M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$4.38M |
| 2 |
BLUE
bluebird bio
BLUE
|
$4.24M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$4.14M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$2.27M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$1.71M |
Sector Composition
| 1 | Healthcare | 82.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Agios Pharmaceuticals
AGIO
$2.19B
| $14.9M | 12.08% | 282,443 +94,943 | +51% | +$5.02M |
|
|
SAGE
2
DELISTED
Sage Therapeutics
SAGE
| $12.3M | 9.94% | 266,500 +38,000 | +17% | +$1.75M |
|
|
FMI
3
DELISTED
Foundation Medicine, Inc.
FMI
| $9.69M | 7.85% | 415,000 +25,000 | +6% | +$584K |
|
|
4
Evolent Health
EVH
$1.12B
| $9.48M | 7.68% | 385,000 +145,500 | +61% | +$3.58M |
|
|
BPMC
5
DELISTED
Blueprint Medicines
BPMC
| $8.52M | 6.9% | 287,000 -53,000 | -16% | -$1.57M |
|
|
LOXO
6
DELISTED
Loxo Oncology, Inc
LOXO
| $7.62M | 6.17% | 291,000 -9,000 | -3% | -$236K |
|
|
GNMK
7
DELISTED
GenMark Diagnostics, Inc
GNMK
| $7.38M | 5.97% | 625,000 +210,000 | +51% | +$2.48M |
|
|
ONCE
8
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $5.62M | 4.55% | 93,500 -69,000 | -42% | -$4.14M |
|
|
GBT
9
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.53M | 4.48% | 240,000 -190,000 | -44% | -$4.38M |
|
|
KITE
10
DELISTED
Kite Pharma, Inc.
KITE
| $5.03M | 4.07% | 90,000 +17,500 | +24% | +$977K |
|
|
BLUE
11
DELISTED
bluebird bio
BLUE
| $4.07M | 3.29% | 60,000 -62,500 | -51% | -$4.24M |
|
|
CLVS
12
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.97M | 3.21% | 110,000 -40,000 | -27% | -$1.44M |
|
13
Voyager Therapeutics
VYGR
$186M
| $3.32M | 2.69% | 276,500 -46,000 | -14% | -$552K |
|
|
EPZM
14
DELISTED
Epizyme, Inc
EPZM
| $2.9M | 2.35% | 295,000 -45,000 | -13% | -$443K |
|
|
15
Exact Sciences
EXAS
$8.98B
| $2.88M | 2.33% | +155,000 | New | +$2.88M |
|
|
16
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.64M | 2.14% | 39,000 -33,500 | -46% | -$2.27M |
|
|
MDRX
17
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.63M | 2.13% | +200,000 | New | +$2.63M |
|
|
MYOK
18
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.61M | 2.12% | 160,000 -19,029 | -11% | -$311K |
|
|
GHDX
19
DELISTED
Genomic Health, Inc.
GHDX
| $2.6M | 2.11% | +90,000 | New | +$2.6M |
|
|
GNMX
20
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $2.09M | 1.69% | 375,000 +290,000 | +341% | +$1.62M |
|
21
CytomX Therapeutics
CTMX
$336M
| $2M | 1.62% | 127,500 -106,679 | -46% | -$1.67M |
|
22
iShares Biotechnology ETF
IBB
$5.6B
| $1.45M | 1.17% | +5,000 | New | +$1.45M |
|
|
RXDX
23
DELISTED
Ignyta, Inc.
RXDX
| $1.23M | 0.99% | 195,000 -180,000 | -48% | -$1.13M |
|
24
Ionis Pharmaceuticals
IONS
$6.79B
| $1.21M | 0.98% | +33,000 | New | +$1.21M |
|
25
Editas Medicine
EDIT
$231M
| $1.15M | 0.93% | +85,470 | New | +$1.15M |
|